A condition characterized by the presence of abnormal quantities of CRYOGLOBULINS in the blood. Upon cold exposure, these abnormal proteins precipitate into the microvasculature leading to restricted blood flow in the exposed areas.
Phase 3 trials (2)
Phase 2 trials (7)
Organization Involved with Phase 3 Indications (2)
Organization Involved with Phase 2 Indications (3)